1. Home
  2. PRSU vs CGEM Comparison

PRSU vs CGEM Comparison

Compare PRSU & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pursuit Attractions and Hospitality Inc.

PRSU

Pursuit Attractions and Hospitality Inc.

HOLD

Current Price

$36.60

Market Cap

946.6M

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$13.08

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSU
CGEM
Founded
1926
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
946.6M
780.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRSU
CGEM
Price
$36.60
$13.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$31.67
$30.11
AVG Volume (30 Days)
208.9K
752.7K
Earning Date
05-07-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.85
N/A
Revenue Next Year
$4.94
N/A
P/E Ratio
$3.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.90
$5.68
52 Week High
$38.71
$16.74

Technical Indicators

Market Signals
Indicator
PRSU
CGEM
Relative Strength Index (RSI) 50.78 43.41
Support Level $32.56 $11.43
Resistance Level $37.75 $13.21
Average True Range (ATR) 1.22 0.94
MACD -0.06 -0.36
Stochastic Oscillator 72.87 1.08

Price Performance

Historical Comparison
PRSU
CGEM

About PRSU Pursuit Attractions and Hospitality Inc.

Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: